Of 391 423 children enrolled in schools with SLV clinics, 61 463 (15.7%) were vaccinated at 499 sites (schools) in 23 programs. Of these, 22 were small-and medium-sized programs that vaccinated 32 875 (24.1%) of the 136 151 children enrolled there, averaging 31.9% of students per site. One populous county vaccinated an additional 28 588 (11.2%) of its 255 272 enrolled children, averaging 13.9% per school. Children in grades K to 6 had consistently higher mean vaccination rates (21.5%) compared with middle school children (10.3%) or high school youth (5.8%). Program acceptability was high, and no program had to forego any key public health activities; 5 hired temporary help or paid overtime. The outlook for continuing such clinics was good in 7 programs, but depended on help with vaccine purchasing (9), funding (8), or additional personnel (4), with multiple responses allowed.
Seasonal influenza is a substantial health burden to school children and their parents each year in the United States. 1 In 2008, the Advisory Committee on Immunization Practices (ACIP) recommended annual influenza vaccination for all children 6 months to 18 years of age. 2 Routine annual vaccination for all children could burden regular immunization providers, however, who may lack the resources needed to comply with this recommendation. 3 Providing school-located vaccination (SLV) clinics to administer seasonal influenza vaccine could reduce this burden on primary care providers and increase vaccination coverage rates among schoolchildren.
We report here the results of pilot SLV programs conducted up to 3 years before the ACIP universal vaccination recommendation and before the 2009 to 2010 influenza pandemic. We describe program effectiveness, logistics, and local acceptability of SLV clinics for seasonal influenza to provide a performance benchmark and help guide such clinics in the future.
METHODS

Participant Selection
Programs were eligible if they conducted 1 or more immunization clinics during the 2005 to 2006 and/or 2006 to 2007 school years in a public or private elementary, middle, or high school in the United States. We compiled a roster of 25 potentially eligible programs from 3 sources. We contacted the immunization program managers of each state, territory, and large county via the Association of Immunization Managers looking for eligible programs. Separately, MedImmune, Inc (Gaithersburg, MD) provided a list of 18 SLV programs it had supported through donations of live, attenuated influenza vaccine (LAIV) and in some cases funding to programs during these school years. We also conducted snowball sampling, a type of purposeful (convenience) sampling method that uses the social networks of already identified programs to identify other programs. 4 All 25 program directors consented to be interviewed. Two programs were subsequently excluded from analysis because they lacked data needed to calculate vaccination coverage rates. Of the 23 remaining programs, 14 were managed by the local health department, 4 by the state health department, 4 by school nurses or administrators without direct health department support, 2 by local physicians aided by the local health department, and 1 by a private company (Table 1) . Vaccination programs were conducted from October 2005 through June 2007. Sixteen programs received free LAIV directly from MedImmune, Inc, whereas others received from their local health department free LAIV and/or trivalent inactivated influenza vaccine (TIV) remaining after local pandemic planning exercises had ended. Twenty-two of these programs were judged to be either small-to medium-sized (∼400-37 000 total student enrollment in the schools where the program was delivered), whereas the single large program had an enrollment of 255 000 children. This project was reviewed by the Human Subjects Contact in the National Center for Immunization and Respiratory Diseases and was determined to be non-research program evaluation.
Data Collection
We developed a semistructured survey instrument to collect information retrospectively. A single interviewer (R.A.S.) conducted telephone interviews with each SLV program director between May 2007 and January 2008. For each site, data were collected concerning the span of grades at that school, the number of children enrolled and vaccinated by grade, and other programmatic information. A child was considered vaccinated if he or she received a single dose at the first (or only) set of clinics offered at that school site. For some children, the ACIP has recommended a second dose 1 or more The survey was developed in part to investigate several concerns articulated by some in public health. On the basis of such conversations, we wrote the instrument assuming that (1) SLV clinics would be difficult to organize because few such clinics had ever been held since mass vaccination clinics for hepatitis B were conducted in the mid1990s, 6 and that few, if any, protocols existed; (2) the programs might tax the resources of local health departments and/or schools; (3) the programs might shift patients away from local medical providers; (4) routine health department work would suffer if health department staff time was used for SLV planning and execution; and (5) school officials and teachers would be reluctant to have SLV clinics in their schools because it might reduce the time available for classroom education.
Open-ended questions were included in the questionnaire to enhance respondent recollection and to gain insight from respondents in their own words. Such data were recorded verbatim, then recoded by using datadeveloped categories. 7 Data were then analyzed by rank order of responses.
Analysis
For analysis of program effectiveness, the school site was the unit of record and the school and the program each served as units of analysis as appropriate. The key outcome variable was the vaccination coverage rate, that is, the proportion of children enrolled in each school (ie, site) who were vaccinated by this program. These values were stratified by grade grouping: grades K to 6, 7 to 8, and 9 to 12. Twenty school sites whose grade was denoted only as "K to 12" were excluded from the age-stratified analysis. No adjustment was made in school enrollment for children absent from school on the clinic day, or for those children with contraindications to vaccination with a live vaccine when it was the only formulation offered. All data are expressed here as unweighted counts and proportions. Because vaccination rates differed greatly within a program and often had a skewed distribution, we calculated the mean, median, and interquartile ranges (IQRs) to indicate the dispersion of values by using Microsoft Excel 2007 rather than conduct more extensive statistical testing that assumed a normal distribution. As a descriptive study, these data were not subjected to hypothesis testing or tests of variability of dispersion, as the sampling method used did not involve the element of chance.
RESULTS
Program Effectiveness
Twenty Table 1 .
Of 391 423 children enrolled in all schools where SLV clinics were held, 61 463 children (15.7%) were vaccinated at the SLV clinic ( Table 2 ). The site-specific median vaccination coverage rate was 17.6% (IQR: 10.0%-31.11%). Vaccination rates varied widely among sites and age groups within a single program and across different programs. Sites with children in grades K to 6 had the highest vaccination coverage rate by site (mean 21.5%, median 20.6%) and the largest proportion of children receiving vaccination (76.2%), despite representing only 55.6% of children enrolled. Of 22 programs, 15 (68.1%) reported using some number of volunteers, who were particularly important in maintaining clinic flow and efficiency in elementary schools. Thirteen programs specified using 1 to 3 volunteers at each clinic, and 2 programs each reported using ∼20 to 40 volunteers. Some programs paired each nurse with a volunteer to enhance throughput. Other volunteers directed the children who had been vaccinated to wait by the room exit until another volunteer led them back to the classroom. Older children returned to their classrooms independently.
The vaccination process began when a volunteer or an older student came to the classroom to accompany eligible children to the SLV clinic site. In most cases, the teacher stayed in the classroom with the other children whose parent(s) did not consent to vaccination. On entry to the clinic site, a school official or volunteer verified the child' s identity at a reception desk (used in each site of 13 programs) and reviewed the consent form for accuracy and completeness. The child would then be triaged to 1 of 2 to 6 stations, each managed by a registered nurse, who would double-check the consent form to ensure correct identification and absence of contraindications to the vaccine before administering it. All vaccinations in all programs were administered by a health professional.
LAIV was used to vaccinate children in all 23 programs. MedImmune, Inc provided free LAIV to 12 programs, and was the sole source of LAIV in 6 of these. Three programs additionally provided TIV to children, as either determined by parental choice in 1 program or by the existence of contraindications to LAIV in 2 others. No serious adverse events were noted to occur.
Among 22 programs reporting roundtrip transit time from classroom to clinic and back, the vaccination process for an entire classroom averaged 18 minutes. Clinics were held in gymnasiums (n = 7), multipurpose/media rooms or libraries (n = 6), auditoriums (n = 2), cafeterias (n = 1), or hallways or other spaces available, according to a plan. Clinics that used the same door for the students' entry and exit noted that a bottleneck and congestion commonly occurred there, which was obviated by using a separate entrance and exit. Twenty-one programs reported clinic duration. Clinics operated between 45 minutes and 12 hours (median of 3 hours and all but 3 programs lasted #4 hours). Fewer than 60 minutes was spent setting up and taking down most sites. Immunization records were maintained in 22 reporting programs by registry (8), paper (3), electronically (3), or not at all (8) . After the clinic ended, 8 programs notified the parent or guardian of the vaccination through a note sent home with the child, 6 programs notified the child's local provider of the vaccination, and 5 depended on a vaccination registry entry alone. Several negative aspects were noted. The problem of insufficient planning time was widely commented on. Some teachers were reportedly concerned that the LAIV used might spread its live (albeit attenuated) virus in the classroom. Three programs reported that 1 or more community physicians objected to the clinics, which was generally a matter of misunderstanding and readily resolved. In fact, 6 program directors reported that private providers had specifically supported the SLV program to their patients. Most programs did not attempt any billing or fee collection. At 1 school with many underserved students, a $10 fee was charged for vaccine administration, and the vaccination coverage rate there was ,5%.
DISCUSSION
In general, these pilot programs were welcomed by those who participated. According to program directors, all but 1 was acceptable to the health department and the school system. This study suggests that mass SLV clinics can be conducted suitably and efficiently at the schools themselves. The chief lessons learned were the need for sufficient planning time, the value of collaboration between the health department and the school systems that is built on an existing relationship, the anticipation of a low initial response rate for parental consents, the value of volunteers in maintaining clinic flow, and the feasibility of vaccinating large numbers of children quickly with only a short interruption of usual classroom academic activities. Many programs received donated or leftover vaccine and help from volunteers, and about half the program directors expressed concern about their ability to conduct future programs without supplemental resources.
Establishing and conducting SLV clinics has some challenges. Their establishment requires a relatively strong relationship between local health department and school system officials and administrators. The amount of planning time and the intensity of conducting the clinics on the day of vaccination is great. A sound public health infrastructure is needed to ensure that sufficient but not excessive quantities of vaccine are ordered, and that the appropriate cold chain is maintained. Wherever possible, members of the medical community who support such SLV clinics should be involved in their planning and, when appropriate, offer their professional vocal support to the local school boards, parents, and others. Local providers may object to SLV clinics held in their area either because of concerns about competition for medical care or about the school vaccination practices. In a recent study, however, only 4% of Maryland pediatricians surveyed indicated an objection to their patients receiving influenza vaccination at a local school site. 8 Finally, at least some second-dose follow-up clinics in our study had difficulty capturing, vaccinating, and/or recording children for whom a second dose was recommended (data not shown). We made no attempt to determine the extent to which SLV services alleviated a parent' s burden of missing work for preventive care. Finally, some pilot programs were conducted at sites where the local health department knew the school officials would be cooperative, a factor that was likely to enhance vaccination rates.
Nevertheless, the results of these pilot clinics are encouraging because they suggest that SLV clinics may be acceptable to school administrators and function well in this environment. Public health and school officials in the programs noted in this study were enthusiastic about their participation. Although the overall mean vaccination coverage rate was low, the higher rates achieved by some programs were encouraging. Access to seasonal influenza vaccination through their school system might increase ease of access for children.
We suggest that further research be directed to several specific areas. Get to know area school administrators and school nurses before requesting participation. They should be present the day(s) the clinic is held.
Obtain written parental consent, although it may be difficult and time-consuming. Often, parents do not return a form, or even receive it in the first place.
Use several methods of contacting parents, and consider asking school office staff to follow up to contact nonresponders.
Accept a wide variety of types of spaces to hold the clinic, including gymnasiums, auditoriums, media centers, unused classrooms, cafeterias, and hallways.
Manage clinic flow carefully. In particular, avoid having too many or too few children in the clinic waiting to be vaccinated. Volunteers can help manage flow.
Have separate entrance and exit doors to improve flow and reduce confusion and congestion.
Incorporate into the system a routine notification-of-vaccination for parents, guardians, and primary care providers of vaccinated children.
